Impact of cognitive training on claims‐based diagnosed dementia over 20 years: evidence from the ACTIVE study
Einfluss eines kognitiven Trainings auf claims-basiert diagnostizierte Demenz über 20 Jahre: Evidenz aus der ACTIVE-Studie
Alzheimer's & Dementia: Translational Research & Clinical Interventions · 2026-01 · 12 (1)
DOI: 10.1002/trc2.70197 ↗Auf einen Blick
Die ACTIVE-Studie untersuchte, ob kognitives Training das Risiko für ADRD über 20 Jahre beeinflusst. In der Speed-Trainingsgruppe war das Risiko bei Teilnehmenden mit Booster-Sitzungen geringer.
Fragestellung
Verändert kognitives Training das Risiko einer claims-basiert diagnostizierten Alzheimer-Krankheit und verwandter Demenzen (ADRD) über 20 Jahre?
Methode
Verknüpfung der ACTIVE-Studie, einer vierarmigen randomisierten kontrollierten Studie, mit Medicare-Claims (1999 bis 2019); Analyse bei Baseline in traditionellem Medicare eingeschlossenen Personen.
Ergebnisse
2021 Teilnehmende. Speed-Training mit ≥1 Booster-Sitzung: HR 0,75 (95 %-KI 0,59–0,95) für diagnostizierte ADRD. Ohne Booster kein reduziertes Risiko: HR 1,01 (95 %-KI 0,81–1,27). Kein Haupteffekt von Gedächtnis- oder Reasoning-Training.
Schlussfolgerung der Autor:innen
Kognitives Training mit Fokus auf Verarbeitungsgeschwindigkeit hat nach Ansicht der Autor:innen das Potenzial, die Diagnose von ADRD zu verzögern.
Kernaussagen
- Speed-Training mit Booster war mit niedrigerem ADRD-Risiko verbunden.
- Ohne Booster zeigte sich kein geringeres Risiko.
- Für Gedächtnis- und Reasoning-Training zeigte sich kein Haupteffekt.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia: Translational Research & Clinical Interventions, online erschienen am 09.02.2026. Verfasst von Norma B Coe und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Ethics and Health Policy Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINR NIH HHS, NIA NIH HHS, National Institute on Aging.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION The very long‐term effect of cognitive training on the risk of Alzheimer's disease and related dementias (ADRD) is unknown. METHODS This study links data from the Advanced Cognitive Training for Independent and Vital Elderly (ACTIVE) study (a four‐arm randomized controlled trial of cognitive training in a large, diverse sample) to Medicare claims (1999 to 2019). Inclusion in the analyses required being enrolled in traditional Medicare at baseline ( n = 2021). ADRD was measured with the Chronic Conditions Warehouse algorithm. RESULTS Participants randomized to the speed‐training arm who completed one or more booster sessions had a significantly lower risk of diagnosed ADRD (hazard ratio [HR]: 0.75, 95% confidence interval [CI]: 0.59, 0.95), while speed‐trained participants with no booster training did not have a lower risk of diagnosed ADRD (HR: 1.01, 95% CI: 0.81, 1.27). There was no main effect of memory or reasoning training on risk of ADRD. CONCLUSIONS Cognitive training involving speed of cognitive processing has the potential to delay the diagnosis of ADRD. Highlights The ACTIVE study (a four‐arm randomized controlled trial of cognitive training in a large, representative sample) reports that the speed intervention arm of the study showed a reduced likelihood of being diagnosed with ADRD over a 20‐year follow‐up period. No prior cognitive training intervention has been shown to reduce risk of ADRD over a 20‐year period. Cognitive training involving speeded, dual attention, adaptive tasks has the potential to delay the diagnosis of ADRD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Ethics and Health Policy Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA.
- National Bureau of Economic Research (NBER) Cambridge Massachusetts USA.
- Department of Health Policy and Management Johns Hopkins Bloomberg School of Public Health Baltimore Maryland USA.
- Department of General Internal Medicine Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA.
- Department of Epidemiology Johns Hopkins Bloomberg School of Public Health Baltimore Maryland USA.
- Department of Psychiatry & Human Behavior Warren Alpert Medical School Brown University Providence Rhode Island USA.
Förderung
- NINR NIH HHS
- NIA NIH HHS
- National Institute on Aging
- National Institutes of Health
- Johns Hopkins University
- New England Research Institutes
- Pennsylvania State University
- University of Alabama at Birmingham
Zitieren
APA
Coe, N. B., Miller, K. E. M., Sun, C., Taggert, E., Gross, A. L., Jones, R. N., Felix, C., Albert, M. S., Rebok, G. W., Marsiske, M., Ball, K. K., & Willis, S. L. (2026). Impact of cognitive training on claims‐based diagnosed dementia over 20 years: evidence from the ACTIVE study. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 12(1). https://doi.org/10.1002/trc2.70197
Vancouver
Coe NB, Miller KEM, Sun C, Taggert E, Gross AL, Jones RN, et al. Impact of cognitive training on claims‐based diagnosed dementia over 20 years: evidence from the ACTIVE study. Alzheimer's & Dementia: Translational Research & Clinical Interventions. 2026;12(1). doi:10.1002/trc2.70197
BibTeX
@article{Coe2026,
author = {Coe, Norma B and Miller, Katherine E M and Sun, Chuxuan and Taggert, Elizabeth and Gross, Alden L and Jones, Richard N and Felix, Cynthia and Albert, Marilyn S and Rebok, George W and Marsiske, Michael and Ball, Karlene K and Willis, Sherry L},
title = {Impact of cognitive training on claims‐based diagnosed dementia over 20 years: evidence from the ACTIVE study},
journal = {Alzheimer's & Dementia: Translational Research & Clinical Interventions},
year = {2026},
volume = {12},
number = {1},
doi = {10.1002/trc2.70197}
}
EUVIMED